The Trump administration pushed out Gail Slater as the Justice Department’s antitrust chief at a key moment for competition enforcement in the tech sector.
Sure, the reverberations of Slater’s exit could be felt in particular court cases and merger probes, like the Netflix deal.
It could also have major ramifications for the populist wing of Trump’s political movement and for Congress’s focus on mergers and monopolies.
Here’s where we’re looking next:
Presented by AstraZeneca
The 340B program was created to help patients. Instead, it’s helping hospitals earn massive profits. The 340B Rebate Model Pilot uses rapid verification of existing data to prevent duplicate discounts, strengthening program transparency and efficiency. Urge HHS to implement the Rebate Model Pilot and ensure 340B functions as intended. Get the facts.
Presented by AstraZeneca
The 340B program is supposed to help vulnerable patients—but without strong safeguards, it’s siphoning away funds that could be used for free and charitable medicine. The 340B Rebate Model Pilot improves program integrity, preventing duplicate discounts and strengthening accountability. Urge HHS to implement the pilot today. Learn why it matters.
You're subscribed! Welcome to the community.
